Among which, ClpP agonists replace the function of ClpX, bind to and activate ClpP to form a tetradecameric barrel structure, and trigger cell apoptosis signaling pathways by degrading proteins of the respiratory chain complex, causing ROS release, impairing mitochondrial function, and activating ISR, ultimately leading to tumor cell death. Here, CLPX is linked to neoplasm.